Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation
11/15/24, 2:00 PM
Location
Industry
medical
biotechnology
health care
manufacturing
Boston Scientific Corporation has successfully closed its acquisition of Axonics, Inc., a medical technology company specializing in devices to treat urinary and bowel dysfunction. This acquisition allows Boston Scientific to expand into sacral neuromodulation, a high-growth adjacency for their Urology business, and to provide a comprehensive product portfolio to patients seeking tailored treatment options for incontinence.
Company Info
Location
Marlborough, Massachusetts, United States
Company info
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

Unlock Strategic Intelligence with Fundz
Access real-time funding updates, strategic shifts with FundzWatch™, exclusive Family Offices, and more — helping you close deals and seize opportunities faster.
Trusted by sales, BD, and investment teams at Oracle, HubSpot, Affinity, and more.
Related people
AH
JH
MH
MH
DH